Researchers from the University of California-Santa Barbara recently announced they have created an implantable “artificial pancreas” that could potentially eliminate the need for insulin injections and pumps for treating type 1 diabetes.
A once-daily dose of 3.0 mg liraglutide, injected subcutaneously, is associated with greater reduction in body weight than placebo, according to a study published in the July 2 issue of the New England Journal of Medicine.
Weight loss of 5% or more, combined with vitamin D3 supplementation, is associated with significant reductions in interleukin-6 in postmenopausal women, according to a study published recently in Cancer Prevention Research.
Three-year outcomes indicate that bariatric surgery is superior to lifestyle intervention alone for inducing remission of type 2 diabetes mellitus (T2DM) in obese patients, according to research published online July 1 in JAMA Surgery.
Obesity is associated with less frequent and less consistent contraceptive use among sexually active 18- to 19-year-old girls, according to research published online July 1 in The Journal of Pediatrics.
Data from two observational registries indicated that long-term testosterone replacement therapy in diabetic men was associated not only with better sexual function and weight loss, but also significant reductions in blood sugar.